{"transactions":[{"id":1765390,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-10-04T17:14:13.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4) of the shares subject to the option will vest on October 2, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to\nReporting Person continuing to be a service provider through each such date."}],"balance_after":200000,"derivative":{"exercise_price":11.37,"expiration_date":"2033-10-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001626199-23-000099","document":"wk-form4_1696454044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1749991/000162619923000099/wk-form4_1696454044.xml","form_type":"4"}},{"id":2030960,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"officer":true,"officer_title":"EVP & CMO"}}],"security":"Common Stock","published_at":"2023-02-06T22:40:17.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":5389,"price":1.6601,"value":8946.2789,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such \"sales to cover\" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,000 shares acquired under the Issuer's stock purchase plan."}],"balance_after":72459,"source":{"system":"sec-edgar","filing":"0001140361-23-004731","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036123004731/form4.xml","form_type":"4"}},{"id":2042511,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"officer":true,"officer_title":"EVP & CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-31T02:45:49.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 26, 2023, it was determined that the performance metric had been met."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully vested on January 26, 2023, the date the determination was made that the performance metric had been met."}],"balance_after":100000,"derivative":{"exercise_price":2.42,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-23-003443","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036123003443/form4.xml","form_type":"4"}},{"id":2074457,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"officer":true,"officer_title":"EVP & CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-30T21:30:46.000Z","date":"2022-12-28","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On December 28, 2022, it was determined that the performance metric had been met."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully vested on December 28, 2022, the date the determination was made that the performance metric had been met."}],"balance_after":50000,"derivative":{"exercise_price":2.42,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-22-047669","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036122047669/form4.xml","form_type":"4"}},{"id":2425462,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T01:46:09.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2022, subject to the reporting person's continuous service to the issuer through each such period"}],"balance_after":100000,"derivative":{"exercise_price":2.42,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-22-001781","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000156761922001781/doc1.xml","form_type":"4"}},{"id":2425461,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CMO"}}],"security":"Common Stock","published_at":"2022-01-27T01:46:09.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from February 1, 2022, with the first annual vest occurring on February 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 17,848 shares acquired under the Issuer's stock purchase plan."}],"balance_after":67848,"source":{"system":"sec-edgar","filing":"0001567619-22-001781","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000156761922001781/doc1.xml","form_type":"4"}},{"id":2523324,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T22:59:30.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted a performance-based option to purchase 37,500 shares of common stock on August 25, 2020. Thus, the exercise price of this option is $2.38 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On November 4, 2021, it was determined that the performance metric had been met."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock subject to the option vest in equal monthly installments over twenty-four (24) months from the vesting commencement date of October 25, 2021, subject to the reporting person's continuous service to the issuer through each such period."}],"balance_after":37500,"derivative":{"exercise_price":2.38,"expiration_date":"2030-08-25","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001567619-21-019427","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000156761921019427/doc1.xml","form_type":"4"}},{"id":2890672,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CMO"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-30T00:10:02.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reporting person was granted a performance-based option to purchase 37,500 shares of common stock on August 25, 2020. Thus, the exercise price of this option is $2.38 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 27, 2021, it was determined that the performance metric had been met."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of common stock subject to the option vest in equal monthly installments over twenty-four (24) months from the vesting commencement date of December 18, 2020, subject to the reporting person's continuous service to the issuer through each such period."}],"balance_after":37500,"derivative":{"exercise_price":2.38,"expiration_date":"2030-08-25","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001179110-21-000986","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911021000986/edgar.xml","form_type":"4"}},{"id":2890671,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CMO"}}],"security":"Stock Option(right to buy)","published_at":"2021-01-30T00:10:02.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2021, subject to the reporting person's continuous service to the issuer through each such period."}],"balance_after":125000,"derivative":{"exercise_price":3.54,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001179110-21-000986","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911021000986/edgar.xml","form_type":"4"}},{"id":3364547,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-21T01:05:23.000Z","date":"2019-11-18","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Common Stock subject to the Option shall vest over a four-year term, with one-fourth of the shares subject to the Option vesting on November 18, 2020, and 1/48th of the shares subject to the Option vesting monthly thereafter, subject to the Continuous Service (as defined in the Plan) to the Company through each vesting date."}],"balance_after":220000,"derivative":{"exercise_price":2.25,"expiration_date":"2029-11-18","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001179110-19-011937","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019011937/edgar.xml","form_type":"4"}},{"id":3426739,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2019-08-29T11:38:17.000Z","date":"2018-12-05","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option vest in equal installments over the 48 months following the date of grant. The original Form 4 stated that vesting occurred in equal annual installments over the same period."}],"balance_after":81094,"derivative":{"exercise_price":8.5,"expiration_date":"2028-12-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-19-047879","document":"a4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1749991/000110465919047879/a4a.xml","form_type":"4/A","original_submission_date":"2018-12-11"}},{"id":3735794,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":109220,"kind":"person","name":"Dummer Wolfgang","position":1,"cik":"0001749991","reported_name":"Dummer Wolfgang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2018-12-11T17:12:02.000Z","date":"2018-12-05","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option vest as follows: in equal annual installments over the 48 months following the date of grant."}],"balance_after":81094,"derivative":{"exercise_price":8.5,"expiration_date":"2028-12-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-18-072393","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1749991/000110465918072393/a4.xml","form_type":"4"}}]}